At a glance
- Originator Otsuka Pharmaceutical
- Class Antibacterials; Cephems
- Mechanism of Action Cell wall inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Bacterial infections
Most Recent Events
- 05 Apr 2001 No-Development-Reported for Bacterial infections in Japan (Parenteral)
- 13 Jun 1995 Preclinical development for Bacterial infections in Japan (Parenteral)
- 09 Jun 1995 New profile